Smith, Gary A.

Objective: The 2010 AHA Guidelines stress the need for minimally interrupted, high quality CPR. We performed a prospective, before/after trial to determine if real-time audiovisual feedback (RTAVF) along with scenario-based training (SBT) would 1) achieve the 2010 CPR targets and 2) improve survival from OHCA. Methods: Data obtained from EMS care forms and defibrillators (E Series, ZOLL) from 2 EMS agencies (population base-500,000). Phase 1 (P1, before): 18 months of baseline data with the RTAVF mode disabled (9/08-3/10). Interventions: 1) Guideline-based SBT of ~450 EMTs, 2) RTAVF enabled, 3) EMT post-code debriefings. Phase 2 (P2, after): 8 months following implementation of interventions (5/10-12/10). For univariate analyses we used Fisher's exact test (proportions), t-test (means) or Kruskal-Wallis test (medians). To estimate odds ratios for survival to hospital discharge we used multivariable logistic regression and assessed final model diagnostics, fit, and discrimination. Results: The final analysis included 284 adult OHCAs (P1-176, P2-108). Mean age 65.4 years (SD ± 15.3) with 66.6% males. Quality measures improved significantly from P1 to P2: Median (Interquartile range) chest compression (CC) rate-121 CC/min (109-135) to 101 CC/min (100-106), p <0.001; CC depth-1.73 in. (1.42-1.97) to 2.09 in. (1.92-2.3), p <0.001; CC fraction-66.5% (59.3-75.9%) to 84.0% (77.8-88.7%), p <0.001. All-rhythms survival increased significantly (p=0.034) from P1 to P2 (18/176, 10.2% vs. 23/108, 19.4%), an absolute survival increase of 9.2% (95% CI: 0.5%-17.9%). Crude odds ratio for survival for P2 vs. P1 was 2.1 (95% CI: 1.1-4.2) and adjusted odds ratio was 5.8 (95% CI: 1.8-18.9), after controlling for confounders including age, sex, location, witnessed arrest, initial rhythm, and therapeutic hypothermia. Survival for arrests with a shockable rhythm was 27.7% (18/65) for P1 and 53.9% (14/26) for P2 (p=0.028). Conclusion: RTAVF combined with SBT was associated with a significant improvement in the proportion of compressions meeting the 2010 AHA Guidelines. This intervention was associated with a 90% relative increase in overall survival. We believe this is the first report to show an improvement in OHCA survival by achieving the 2010 AHA CPR Guidelines.

Background: Prior studies have not examined national trends and characteristics of unintentional non–health care facility (HCF) medication errors associated with cardiovascular drugs. Objective: To investigate non-HCF medication errors associated with cardiovascular drugs reported to poison control centers in the United States. Methods: A retrospective analysis of non-HCF medication errors associated with cardiovascular drugs from 2000 to 2012 was conducted using the National Poison Data System database. Results: There were 278 444 medication errors associated with cardiovascular drugs reported to US poison control centers during the study period, averaging 21 419 exposures annually. The overall rate of cardiovascular medication errors per 100 000 population increased 104.6% from 2000 to 2012 ( P < 0.001) and the highest rates were among older adults. Most cases (83.6%) did not require treatment at a HCF. Serious medical outcomes were reported in 4.0% of exposures. The cardiovascular drugs most commonly implicated in medication errors were β-blockers (28.2%), calcium antagonists (17.7%), and angiotensin-converting enzyme inhibitors (15.9%). Most of the 114 deaths were associated with cardiac glycosides (47.4%) or calcium antagonists (29.8%). Most medication errors involved taking or being given a medication twice (52.6%). Conclusions: This study describes characteristics and trends of non-HCF cardiovascular medication errors over a 13-year period in the United States. The number and rate of cardiovascular medication errors increased steadily from 2000 to 2012, with the highest error rates among older adults. Further research is needed to identify prevention strategies for these errors, with a particular focus on the older adult population.

The goals of this study were to evaluate the validity of the visual analogue scale (VAS) for young children and to compare a newly developed method of teaching children to use a VAS with one used in our previous studies. It was hypothesized that the new method would increase the number of children who understand the VAS and correctly mark their responses on the VAS line. The association between child's age and ability to understand the VAS was also evaluated. One hundred-six children with a laceration requiring sutures and receiving a lidocaine injection for local anesthesia participated in the study. They ranged in age from 5 to 14 years. Two outcome measures were used to assess the baseline and lidocaine injection pain: a 5-point Likert scale and a VAS. A calibration study was used to determine whether the subjects were able to use the VAS to make proportional judgments about their perceptions. Teaching method had no effect on the number of subjects who could correctly mark their responses on the VAS line, nor did it significantly increase the number of subjects who could understand the concept of the VAS. Subjects who were able to understand the VAS were significantly older (mean = 9.8 years, SD = 2.8) than those who did not (mean = 8.2 years, SD = 2.5). Overall, only about one third of the subjects were able to correctly mark the VAS and understand the concept of the VAS. Other measures of pain that are better understood by young children may be more valid indicators of pain than the VAS.